# Insys Therapeutics

Source: https://onco.cc/companies/insys-therapeutics/  
OnCo record `insys-therapeutics` (Company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Insys Therapeutics was an Arizona company whose sublingual fentanyl spray for breakthrough cancer pain went through phase 3 trials; its marketing practices later led to criminal convictions and bankruptcy.

## Summary

Insys Therapeutics, founded in 1990 and based in Chandler, Arizona, developed Subsys, a fentanyl sublingual spray approved for breakthrough pain in opioid-tolerant cancer patients, and a dronabinol oral solution. Its executives were convicted in 2019 over kickbacks to prescribers, and the company filed for bankruptcy the same year. Its phase 3 trials in cancer pain remain on ClinicalTrials.gov under Insys as lead sponsor.

## Fields

- Kind: Company
- Last checked: 2026-09-11
- Also known as: INSYS Therapeutics Inc; Insys Therapeutics, Inc.
- Tags: ctgov-sponsor
- HQ: Chandler, AZ
- Type: pharma
- Website: http://www.insysrx.com

## Sources

- Official website: http://www.insysrx.com
- ClinicalTrials.gov: trials led by INSYS Therapeutics Inc: https://clinicaltrials.gov/search?lead=INSYS%20Therapeutics%20Inc
- Wikidata: https://www.wikidata.org/wiki/Q19903344

## Connected records

- fronts: [Supportive Care & Survivorship](https://onco.cc/fronts/supportive-care/)
- terms: [Clinical trial](https://onco.cc/terms/clinical-trial/), [Pivotal (registrational) trial](https://onco.cc/terms/pivotal-trial/)

---
JSON: https://onco.cc/api/v1/entities/insys-therapeutics.json